6-amino-2-butylamino-9-(4-morpholin-4-ylmethylbenzyl)-7,9-dihydropurin-8-one | 1059069-73-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 咪唑并嘧啶类
• 英文名称: 6-amino-2-butylamino-9-(4-morpholin-4-ylmethylbenzyl)-7,9-dihydropurin-8-one
• 英文别名: 6-amino-2-(butylamino)-9-[[4-(morpholin-4-ylmethyl)phenyl]methyl]-7H-purin-8-one
• CAS: 1059069-73-6
• 化学式: C₂₁H₂₉N₇O₂
• 分子量: 411.507
• InChiKey: ZYKDWZMYBHWRBY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  30
• 可旋转键数：
  8
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.48
• 拓扑面积：
  109
• 氢给体数：
  3
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  4-(氯甲基)苯甲基醇 在 盐酸 、 氯化亚砜 、 水 、 溴 、 sodium acetate 、 potassium carbonate 、 N,N-二异丙基乙胺 作用下， 以 二氯甲烷 、 氯仿 、 N,N-二甲基甲酰胺 为溶剂， 生成 6-amino-2-butylamino-9-(4-morpholin-4-ylmethylbenzyl)-7,9-dihydropurin-8-one
  参考文献：
  名称：

  Synthesis and evaluation of 8-oxoadenine derivatives as potent Toll-like receptor 7 agonists with high water solubility

  摘要：

  We report the discovery of novel series of highly potent TLR7 agonists based on 8-oxoadenines, 1 and 2 by introducing and optimizing various tertiary amines onto the N(9)-position of the adenine moiety. The introduction of the amino group resulted in not only improved water solubility but also enhanced TLR7 agonistic activity. In particular compound 20 (DSR-6434) indicated an optimal balance between the agonistic potency and high water solubility. It also demonstrated a strong antitumor effect in vivo by intravenous administration in a tumor bearing mice model. (c) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.11.114

文献信息

• NOVEL ADENINE COMPOUND
  申请人：Isobe Yoshiaki

  公开号：US20100093998A1

  公开（公告）日：2010-04-15

  A novel adenine compound represented by the formula (1): wherein A represents an (un)substituted aromatic carbocycle or (un)substituted aromatic heterocycle; L 1 and L 2 each independently represents straighted or branched alkylene, etc.; R 1 represents halogen, (un)substituted alkyl, (un)substituted alkenyl, (un)substituted alkynyl, (un)substituted cycloalkyl, (un)substituted aryl, or (un)substituted heteroaryl; R 2 and R 3 each independently represents hydrogen, or (un)substituted alkyl, (un)substituted alkenyl, (un)substituted alkynyl, (un)substituted cycloalkyl, (un)substituted saturated heterocycle, (un)substituted aryl, or (un)substituted heteroaryl, or R 2 combines together with L 2 or R 3 to form (un)substituted 4- to 8-membered nitrogen-containing saturated heterocycle; X is oxygen, sulfur, SO, SO 2 , NR 7 , NR 7 CO wherein R 7 is hydrogen or alkyl, or a single bond; provided that X is a single bond when R 1 is halogen, or a pharmaceutically acceptable salt thereof. The compound and salt are useful as a medicine.

  一种新型腺嘌呤化合物，其化学式为（1）：其中A代表（未）取代的芳香族碳环或（未）取代的芳香族杂环；L1和L2各自独立地代表直链或支链烷基等；R1代表卤素，（未）取代的烷基，（未）取代的烯基，（未）取代的炔基，（未）取代的环烷基，（未）取代的芳基或（未）取代的杂芳基；R2和R3各自独立地代表氢，或（未）取代的烷基，（未）取代的烯基，（未）取代的炔基，（未）取代的环烷基，（未）取代的饱和杂环，（未）取代的芳基或（未）取代的杂芳基，或R2与L2或R3结合形成（未）取代的含氮饱和杂环，其大小为4到8个成员；X为氧、硫、SO、SO2、NR7、NR7CO，其中R7为氢或烷基，或单键；但当R1为卤素时，X为单键，或其药学上可接受的盐。该化合物及其盐可用作药物。
• Synthesis and evaluation of 8-oxoadenine derivatives as potent Toll-like receptor 7 agonists with high water solubility
  作者：Tomoaki Nakamura、Hiroki Wada、Hirotaka Kurebayashi、Tom McInally、Roger Bonnert、Yoshiaki Isobe

  DOI：10.1016/j.bmcl.2012.11.114

  日期：2013.2

  We report the discovery of novel series of highly potent TLR7 agonists based on 8-oxoadenines, 1 and 2 by introducing and optimizing various tertiary amines onto the N(9)-position of the adenine moiety. The introduction of the amino group resulted in not only improved water solubility but also enhanced TLR7 agonistic activity. In particular compound 20 (DSR-6434) indicated an optimal balance between the agonistic potency and high water solubility. It also demonstrated a strong antitumor effect in vivo by intravenous administration in a tumor bearing mice model. (c) 2012 Elsevier Ltd. All rights reserved.